Journey Medical Corporation (DERM)
NASDAQ: DERM · IEX Real-Time Price · USD
3.450
-0.170 (-4.70%)
May 17, 2024, 4:30 PM EDT - Market closed
Journey Medical Market Cap
Journey Medical has a market cap or net worth of $70.25 million as of May 17, 2024. Its market cap has increased by 140.57% in one year.
Market Cap
70.25M
Enterprise Value
63.96M
1-Year Change
140.57%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since the IPO on November 12, 2021, Journey Medical's market cap has decreased from $157.79M to $70.25M, a decrease of -55.48%. That is a compound annual growth rate of -27.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 69.00M | -4.70% |
May 16, 2024 | 72.40M | 0.84% |
May 15, 2024 | 71.80M | -0.55% |
May 14, 2024 | 72.20M | 9.23% |
May 13, 2024 | 66.10M | 1.69% |
May 10, 2024 | 65.00M | -0.46% |
May 9, 2024 | 65.30M | -1.21% |
May 8, 2024 | 66.10M | 3.77% |
May 7, 2024 | 63.70M | -3.04% |
May 6, 2024 | 65.70M | -3.81% |
May 3, 2024 | 68.30M | 1.64% |
May 2, 2024 | 67.20M | 3.38% |
May 1, 2024 | 65.00M | -4.83% |
Apr 30, 2024 | 68.30M | 10.88% |
Apr 29, 2024 | 61.60M | -2.07% |
Apr 26, 2024 | 62.90M | -2.93% |
Apr 25, 2024 | 64.80M | 3.02% |
Apr 24, 2024 | 62.90M | -3.97% |
Apr 23, 2024 | 65.50M | - |
Apr 22, 2024 | 65.50M | 1.71% |
Apr 19, 2024 | 64.40M | -2.87% |
Apr 18, 2024 | 66.30M | -7.14% |
Apr 17, 2024 | 71.40M | 1.56% |
Apr 16, 2024 | 70.30M | -5.51% |
Apr 15, 2024 | 74.40M | -9.05% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
LAVA Therapeutics | 75.71M |
Neuronetics | 75.00M |
Cryo-Cell International | 74.97M |
P3 Health Partners | 74.86M |
Bionano Genomics | 74.20M |
Tempest Therapeutics | 73.98M |
CollPlant Biotechnologies | 73.02M |
Marinus Pharmaceuticals | 72.79M |